Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Advances in malignant melanoma
Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany
Advances in malignant melanoma ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )
11 Nov 2016
How does the protein kinase Akt enable tumours to grow?
Dr Igor Vivanco - The Institute of Cancer Research, London, UK
How does the protein kinase Akt enable tumours to grow? ( Dr Igor Vivanco - The Institute of Cancer Research, London, UK )
11 Nov 2016
Using adoptive cell therapy to fight cancer
Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA
Using adoptive cell therapy to fight cancer ( Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA )
11 Nov 2016
What does palbociclib do and what side effects might we see?
Dr Alison Jones - The LOC, London, UK
What does palbociclib do and what side effects might we see? ( Dr Alison Jones - The LOC, London, UK )
8 Nov 2016
History and progress of CD38 in myeloma
Dr Fabio Malavasi - University of Turin, Turin, Italy
History and progress of CD38 in myeloma ( Dr Fabio Malavasi - University of Turin, Turin, Italy )
2 Nov 2016
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )
2 Nov 2016
Monoclonal antibodies in multiple myeloma
Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France
Monoclonal antibodies in multiple myeloma ( Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France )
1 Nov 2016
How can we make the best decisions for health whilst considering cost?
Dr Andrea Manca - University of York, York, UK
How can we make the best decisions for health whilst considering cost? ( Dr Andrea Manca - University of York, York, UK )
1 Nov 2016
Preemptively treating patients most at risk of progression to myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Preemptively treating patients most at risk of progression to myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
1 Nov 2016
Drug combos with daratumumab likely to become standard of care in myeloma
Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland
Drug combos with daratumumab likely to become standard of care in myeloma ( Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland )
1 Nov 2016
Overview of the CD38 antibody in multiple myeloma
Dr Torben Plesner - Vejle Hospital, Vejle, Denmark
Overview of the CD38 antibody in multiple myeloma ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )
1 Nov 2016
New drugs and combinations in haematological cancers improve complete remission...
Dr Paolo Corradini - University of Milan, Milan, Italy
New drugs and combinations in haematological cancers improve complete remission rates ( Dr Paolo Corradini - University of Milan, Milan, Italy )
1 Nov 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation